Perrigo, the leading maker of private-label over-the-counter drugs, is once again testing investors’ patience with a surprise management change. But that unsettling news also creates a future opportunity.
from WSJ.com: US Business https://ift.tt/2ytzN44
via IFTTT
No comments:
Post a Comment